Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2018

Jan 25, 2018

34395_dirs_2018-01-25_d626f418-4a21-4765-9825-67e618ab4f47.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2018-01-23

Reporting Person: Skaff Habib (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-01-23 Stock Option (Right to Buy) $4 A 10000 Acquired 2024-01-23 Common Stock (10000) Direct

Footnotes

F1: A total of 10,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.